Walter M Stadler MD

Genitourinary Oncology, Hematologic Oncology

Chief Clinical Officer and Professor, Department of Medical Oncology & Therapeutics Research

2520 Elisha AveM/C 2115Zion, IL 60099
Phone+1 888-969-2822
Fax+1 847-731-1017

Dr. Stadler is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stadler's full profile Already have an account?

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 1991 - 1994
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1988 - 1991
Yale School of MedicineClass of 1988

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IL State Medical License 1990 - 2029
IN State Medical License 2023 - 2027
WI State Medical License 2022 - 2027
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Chicago Magazine: Top Doctors Castle Connolly
America's Top Doctors Castle Connolly
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017

Clinical Trials

Oxaliplatin in Treating Patients With Metastatic Bladder Cancer Start of enrollment: 2000 Feb 01
Completed
Phase 2
O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma Start of enrollment: 2000 Jun 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer Start of enrollment: 1999 Aug 01
Completed
Phase 2

Publications & Presentations

PubMed

Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma.
Anishka A D'Souza, Susan G Groshen, Denice Tsao-Wei, Nora Ruel, Tanya B Dorff
Current Problems in Cancer. 2026-08-01
Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.
Rana R McKay, Michael Serzan, Wanling Xie, Bradley A McGregor, David Braun
Journal for Immunotherapy of Cancer. 2026-07-01
A Prospective Study of Stereotactic Body Radiation Therapy in Oligometastatic Renal Cell Carcinoma.
Rohan R Katipally, Greeshma Rajeev-Kumar, Abhishek A Solanki, Fauzia Arif, Scott E Eggener
International Journal of Radiation Oncology, Biology, Physics. 2026-05-01

Journal Articles

Publisher Correction: Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination with Bevacizumab Versus Sunitinib in Renal Cell Ca...
Michael B Atkins, Mario Sznol, Robert J Motzer, Richard W Joseph, Thomas Hutson, John Hainsworth, W Kimryn Rathmell, Brian I Rini, David F McDermott, Toni K Choueiri, ..., Nature
Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination with Bevacizumab Versus Sunitinib in Renal Cell Carcinoma
Michael B Atkins, Thomas Hutson, Mario Sznol, Toni K Choueiri, Sumanta K Pal, Richard W Joseph, John Hainsworth, W Kimryn Rathmell, David F McDermott, Robert J Motzer,..., Nature

Authored Content

Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic CancersJanuary 2018

Press Mentions

The Overlooked Complexity of Outpatient Cancer Care, Per 11 LeadersApril 13th, 2026
Beyond Volume and Survival: Rethinking Cancer Care MetricsFebruary 28th, 2026
Why Cancer Survivorship Care Needs a Redesign, Per 10 LeadersFebruary 2nd, 2026

Grant Support

Protocol Review And Monitoring SystemNational Cancer Institute2008–2012
Dynamic-Contrast Enhanced MRI As A BAY 43-9006 MarkerNational Cancer Institute2005–2006
Biomarkers For Bladder Cancer Chemoprevention TrialsNational Cancer Institute1998–1999